Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

CLEVELAND DERMATOLOGICAL SOCIETY

CLEVELAND DERMATOLOGICAL SOCIETY This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract Psoriasis with Cancerous Nodule Formation on Lower Extremities. Presented by Dr. T. A. Ballien and Dr. R. J. Hilfer for Dr. H. H. Johnson and Dr. I. L. Schonberg. DISCUSSION Dr. H. J. Parkhurst: Epitheliomas developed after this patient had had psoriasis for many years, and on examining his hands I found numerous keratoses, which raised the question as to whether or not arsenic might not be a causal factor in the cancerous condition.Dr. G. M. Stroud: As a therapeutic suggestion, I would like to mention my experience with a drug exhibited at the Academy meeting, namely pyromen,® which is a sterile carbohydrate used for intravenous injection. Its action is to stimulate the reticuloendothelial system and increase the secretion of adrenocortical hormones. The dose ranges between 1 and 5 γ for ambulatory use, which is the way I used it for four patients with psoriasis. In three of these, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png A.M.A. Archives of Dermatology & Syphilology American Medical Association

CLEVELAND DERMATOLOGICAL SOCIETY

Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/cleveland-dermatological-society-TTxR17f3Vl

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1951 American Medical Association. All Rights Reserved.
ISSN
0096-5979
DOI
10.1001/archderm.1951.01570100148027
Publisher site
See Article on Publisher Site

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract Psoriasis with Cancerous Nodule Formation on Lower Extremities. Presented by Dr. T. A. Ballien and Dr. R. J. Hilfer for Dr. H. H. Johnson and Dr. I. L. Schonberg. DISCUSSION Dr. H. J. Parkhurst: Epitheliomas developed after this patient had had psoriasis for many years, and on examining his hands I found numerous keratoses, which raised the question as to whether or not arsenic might not be a causal factor in the cancerous condition.Dr. G. M. Stroud: As a therapeutic suggestion, I would like to mention my experience with a drug exhibited at the Academy meeting, namely pyromen,® which is a sterile carbohydrate used for intravenous injection. Its action is to stimulate the reticuloendothelial system and increase the secretion of adrenocortical hormones. The dose ranges between 1 and 5 γ for ambulatory use, which is the way I used it for four patients with psoriasis. In three of these,

Journal

A.M.A. Archives of Dermatology & Syphilology – American Medical Association

Published: Oct 1, 1951

There are no references for this article.